Back to HomeBeta

ICD-10 Coding for Renal Carcinoma(C64.1, C64.2, C64.9)

Complete ICD-10-CM coding and documentation guide for Renal Carcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Kidney CancerRenal Cell CarcinomaRCC

Related ICD-10 Code Ranges

Complete code families applicable to Renal Carcinoma

C64-C65Primary Range

Malignant neoplasms of kidney, except renal pelvis

This range includes the primary codes for renal carcinoma, focusing on the kidney excluding the renal pelvis.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C64.1Malignant neoplasm of right kidney, except renal pelvisUse when the right kidney is confirmed to have a malignant neoplasm, excluding the renal pelvis.
  • Biopsy-confirmed clear cell renal cell carcinoma
  • Imaging showing right kidney mass
C64.2Malignant neoplasm of left kidney, except renal pelvisUse when the left kidney is confirmed to have a malignant neoplasm, excluding the renal pelvis.
  • Biopsy-confirmed papillary renal cell carcinoma
  • Imaging showing left kidney mass
C64.9Malignant neoplasm of unspecified kidney, except renal pelvisUse when the laterality of the kidney involvement is not specified.
  • Biopsy-confirmed renal cell carcinoma without specified laterality
  • Imaging showing renal mass without specified laterality

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for renal carcinoma

Essential facts and insights about Renal Carcinoma

The ICD-10 code for renal carcinoma includes C64.1 for right kidney, C64.2 for left kidney, and C64.9 for unspecified laterality.

Primary ICD-10-CM Codes for renal carcinoma

Malignant neoplasm of right kidney, except renal pelvis
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed right kidney mass via imaging or biopsy

Applicable To

  • Right kidney involvement

Excludes

  • Malignant neoplasm of renal pelvis (C65.1)

Clinical Validation Requirements

  • Biopsy-confirmed clear cell renal cell carcinoma
  • Imaging showing right kidney mass

Code-Specific Risks

  • Misidentifying laterality
  • Incorrect histologic subtype documentation

Coding Notes

  • Ensure laterality is documented clearly to avoid using unspecified codes.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Other specified disorders of kidney and ureter

N28.89
Use for associated acquired cystic kidney disease.

Personal history of malignant neoplasm of kidney

Z85.058
Use for patients with a history of kidney cancer.

Gross hematuria

R31.0
Use for associated symptoms like hematuria.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of right renal pelvis

C65.1
Involvement of the renal pelvis rather than the kidney parenchyma.

Malignant neoplasm of left renal pelvis

C65.2
Involvement of the renal pelvis rather than the kidney parenchyma.

Malignant neoplasm of unspecified renal pelvis

C65.9
Involvement of the renal pelvis rather than the kidney parenchyma.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Renal Carcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C64.1.

Impact

Clinical: May affect treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential for claim denials.

Mitigation Strategy

Ensure histologic subtype is included in pathology reports., Cross-check clinical notes for completeness.

Impact

Reimbursement: May lead to denied claims or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.

Mitigation Strategy

Ensure laterality is clearly documented and use specific codes.

Impact

Failure to document laterality can lead to incorrect coding.

Mitigation Strategy

Implement mandatory laterality checks in clinical documentation.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Renal Carcinoma, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Renal Carcinoma

Use these documentation templates to ensure complete and accurate documentation for Renal Carcinoma. These templates include all required elements for proper coding and billing.

Biopsy-confirmed renal cell carcinoma

Specialty: Oncology

Required Elements

  • Laterality
  • Histologic subtype
  • Tumor size
  • Extension beyond kidney

Example Documentation

Patient presents with a 4.5 cm clear cell RCC in the right kidney, confirmed by biopsy.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Kidney cancer, needs treatment.
Good Documentation Example
4.5 cm clear cell RCC in the right kidney, confirmed by biopsy, with no extension beyond Gerota’s fascia.
Explanation
The good example provides specific details about the tumor, laterality, and histologic subtype.

Need help with ICD-10 coding for Renal Carcinoma? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more